Metastatic Colorectal Cancers Completed Phase 2 Trials for Regorafenib (DB08896)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03898102Zinc Supplement in Regorafenib Treated mCRC PatientTreatment
NCT02699073Evaluation of Treatment Response With CHOI and RECIST Criteria and CT Texture Analysis in Patients With Metastatic Colorectal Cancer Treated With RegorafenibTreatment